The effect of Nigella sativa oil and Dichlophenac Gel on the reduction of knee Osteoarthritis pai

Phase 3

• Conditions: Patients with knee osteoarthritis based on clinical and radiological criteria of the American College of Rheumatology (ACR = 2_3).; Osteopathies and chondropathies; 80-M94

• Registration Number: IRCT20181211041923N1
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

Patiant with knee osteoarthritis based on ACR=2_3 and clinical standard
Satisfaction to enter the study

Exclusion Criteria

Joint effusion
Arthritis
Liver and kidney failure
Consumption of neurological drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain based on the Visual Analogue Scale (VAS). Timepoint: At the beginning of the study (before the intervention) and 3 weeks after starting the drug administration. Method of measurement: Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
The intensity of osteoarthritis based on the KellgreneLawrence scale. Timepoint: At the beginning of the study (before the intervention) and 3 weeks after starting the drug administration. Method of measurement: KellgreneLawrence scale.;Patients knee conditions based on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Timepoint: At the beginning of the study (before the intervention) and 3 weeks after starting the drug administration. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).